(Q35190163)

7 August 2017

1 reference

title

Clinical development of gene therapy for colorectal cancer (English)

1 reference

7 August 2017

0 references

1 reference

1 reference

David Kerr

1

1 reference

PubMed ID

12894249

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

7 August 2017

Nature Reviews Cancer

1 reference

7 August 2017

3

1 reference

7 August 2017

615-622

1 reference

7 August 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc1147

7 August 2017

0 references

cites work

A genetic model for colorectal tumorigenesis

1 reference

Localization of the gene for familial adenomatous polyposis on chromosome 5.

31 March 2020

1 reference

Molecular analysis of APC mutations in familial adenomatous polyposis and sporadic colon carcinomas

31 March 2020

1 reference

31 March 2020

1 reference

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

31 March 2020

1 reference

Can immunotherapy by gene transfer tip the balance against colorectal cancer?

31 March 2020

1 reference

The EGF receptor family as targets for cancer therapy

31 March 2020

1 reference

Carcinoembryonic antigen gene family: molecular biology and clinical perspectives

31 March 2020

1 reference

The colorectal cancer gene hunt: current findings

31 March 2020

1 reference

Lessons from hereditary colorectal cancer

31 March 2020

1 reference

Polymorphisms and colorectal tumor risk

31 March 2020

1 reference

Prerequisites for effective adenovirus mediated gene therapy of colorectal liver metastases in the rat using an intracellular neutralizing antibody fragment to p21-Ras

31 March 2020

1 reference

In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase

31 March 2020

1 reference

Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity

31 March 2020

1 reference

Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells

31 March 2020

1 reference

Intratumoral adenovirus-mediated suicide gene transfer for hepatic metastases from colorectal adenocarcinoma: results of a phase I clinical trial

31 March 2020

1 reference

Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase

31 March 2020

1 reference

Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine

31 March 2020

1 reference

Virus directed enzyme prodrug therapy for ovarian and pancreatic cancer using retrovirally delivered E. coli nitroreductase and CB1954.

31 March 2020

1 reference

In vivo human carboxylesterase cDNA gene transfer to activate the prodrug CPT-11 for local treatment of solid tumors

31 March 2020

1 reference

Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans

31 March 2020

1 reference

Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7.

31 March 2020

1 reference

Cytokine gene therapy with interleukin-2-transduced fibroblasts: effects of IL-2 dose on anti-tumor immunity

31 March 2020

1 reference

Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: phase I/II experience

31 March 2020

1 reference

Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma

31 March 2020

1 reference

Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine

31 March 2020

1 reference

Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replicating avian pox virus to enhance T-cell immunity and antitumor responses

31 March 2020

1 reference

Phase I study in cancer patients of a replication-defective avipox recombinant vaccine that expresses human carcinoembryonic antigen

31 March 2020

1 reference

Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule

31 March 2020

1 reference

Replicating viruses as selective cancer therapeutics

31 March 2020

1 reference

Squalene: potential chemopreventive agent

31 March 2020

1 reference

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

31 March 2020

1 reference

Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial

31 March 2020

1 reference

Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor-specific gene therapy

31 March 2020

1 reference

Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase

31 March 2020

1 reference

Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies.

31 March 2020

1 reference

Identification of FGF receptor-binding peptides for cancer gene therapy

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC1147

1 reference

7 August 2017

1 reference

PubMed ID

12894249